Sensorion
Sensorion's email is contact@sensorion-pharma.com
and
Sensorion's phone number is 33467207730
.
Sensorion, a Clapiers, France-based biopharmaceutical company specifically dedicated to the development of innovative and targeted therapeutic solutions to treat vestibular deficits.
View Top Employees for Sensorion
|
Industry | Medical Practice |
|
Location | France |
|
Employees | 10 |
|
Founded | 2009 |
|
HQ | Pépinière Cap ALPHA Avenue de l'Europe |
|
Phone | 3346-720-7730 |
|
contact@sensorion-pharma.com | |
|
Funding | 4,750,000 EUR |
|
Competitors | Hamad Medical Corpora..., Sescam, Me Stesso Myself, Palo Alto Medical Fou..., Médecins Sans Frontiè..., Uz Leuven, |
|
|
Industry | Medical Practice |
|
|
Location | France |
|
|
Employees | 10 |
|
|
Founded | 2009 |
|
linkedin.com/company/sensorion | |
|
|
HQ | Pépinière Cap ALPHA Avenue de l'Europe |
|
|
Phone | 3346-720-7730 |
|
|
contact@sensorion-pharma.com | |
|
|
Funding | 4,750,000 EUR |
Top Competitors for Sensorion
Sensorion Questions
Where are Sensorion's headquarters?
Sensorion's headquarters are in Pépinière Cap ALPHA Avenue de l'Europe
What is Sensorion's phone number?
Sensorion's phone number is 33467207730
How many employees are working in Sensorion right now?
Sensorion has
10 employees.
View the Email and Phone Numbers for all 10 working at Sensorion.
What is Sensorion's industry?
Sensorion's industry is
Medical Practice
Who are Sensorion's top competitors?
Sensorion's top competitors are
Hamad Medical Corporation
,
Sescam
,
Me Stesso Myself
,
Palo Alto Medical Foundation
,
Médecins Sans Frontières (Msf)
,
Uz Leuven
What is Sensorion's email address?
Sensorion's email address is contact@sensorion-pharma.com
What are Sensorion's categories?
Sensorion's categories are Biopharma, Biotechnology, Therapeutics
What is Sensorion's location?
Sensorion's location is
France
When was Sensorion's founded?
Sensorion's founding year is 2009
What is Sensorion's funding?
Sensorion's funding is 4,750,000 EUR
What is Sensorion's current status?
Sensorion's current status is ipo
